GV 2016, L.P. 13D and 13G filings for Arcus Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-14 12:30 pm Sale | 2021-12-31 | 13G | Arcus Biosciences, Inc. RCUS | GV 2016, L.P. | 2,563,441 3.650% | -2,486,345![]() (-49.24%) | Filing |